Deferred Tax Assets, Valuation Allowance of ACRO BIOMEDICAL CO., LTD. from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ACRO BIOMEDICAL CO., LTD. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • ACRO BIOMEDICAL CO., LTD. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $6,891,148, a 0.28% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ACRO BIOMEDICAL CO., LTD. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,891,148 +$19,319 +0.28% 31 Dec 2025 10-K 11 Feb 2026 2025 FY
Q4 2024 $6,871,829 +$7,971 +0.12% 31 Dec 2024 10-K 11 Feb 2026 2025 FY
Q4 2023 $6,863,858 +$1,848,917 +37% 31 Dec 2023 10-K 24 Jul 2025 2024 FY
Q4 2022 $5,014,941 +$3,332,645 +198% 31 Dec 2022 10-K 18 Jul 2025 2023 FY
Q4 2021 $1,682,296 +$1,615,651 +2424% 31 Dec 2021 10-K 21 Jul 2023 2022 FY
Q3 2021 $91,351 +$41,025 +82% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 $76,233 +$40,930 +116% 30 Jun 2021 10-Q 23 Aug 2021 2021 Q2
Q1 2021 $78,613 +$56,492 +255% 31 Mar 2021 10-Q 24 May 2021 2021 Q1
Q4 2020 $66,645 +$27,397 +70% 31 Dec 2020 10-K 15 Apr 2022 2021 FY
Q3 2020 $50,326 +$26,919 +115% 30 Sep 2020 10-Q 17 Nov 2020 2020 Q3
Q2 2020 $35,303 30 Jun 2020 10-Q 19 Aug 2020 2020 Q2
Q1 2020 $22,121 31 Mar 2020 10-Q 19 May 2020 2020 Q1
Q4 2019 $39,248 +$39,248 31 Dec 2019 10-K 02 Apr 2021 2020 FY
Q3 2019 $23,407 -$8,635 -27% 30 Sep 2019 10-KT 27 Mar 2020 2020 FY
Q4 2018 $0 -$4,765 -100% 31 Dec 2018 10-KT 27 Mar 2020 2020 FY
Q3 2018 $32,042 $0 0% 30 Sep 2018 10-KT 27 Mar 2020 2020 FY
Q4 2017 $4,765 31 Dec 2017 10-Q 14 Feb 2018 2018 Q1
Q3 2017 $32,042 +$764 +2.4% 30 Sep 2017 10-K 28 Dec 2018 2018 FY
Q3 2016 $31,278 +$14,766 +89% 30 Sep 2016 10-K/A 16 Jan 2018 2017 FY
Q3 2015 $16,512 30 Sep 2015 10-K 16 Dec 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.